- Home
- CATO vs ACHV Comparison
CATO vs ACHV Comparison
Compare CATO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- ACHV
- Stock Information
- Founded
- CATO 1946
- ACHV N/A
- Country
- CATO United States
- ACHV Canada
- Employees
- CATO N/A
- ACHV N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CATO Consumer Discretionary
- ACHV Health Care
- Exchange
- CATO Nasdaq
- ACHV Nasdaq
- Market Cap
- CATO 63.9M
- ACHV 72.5M
- IPO Year
- CATO N/A
- ACHV N/A
- Fundamental
- Price
- CATO $2.58
- ACHV $2.35
- Analyst Decision
- CATO
- ACHV Strong Buy
- Analyst Count
- CATO 0
- ACHV 3
- Target Price
- CATO N/A
- ACHV $14.33
- AVG Volume (30 Days)
- CATO 43.3K
- ACHV 178.2K
- Earning Date
- CATO 05-22-2025
- ACHV 05-13-2025
- Dividend Yield
- CATO 13.33%
- ACHV N/A
- EPS Growth
- CATO N/A
- ACHV N/A
- EPS
- CATO N/A
- ACHV N/A
- Revenue
- CATO $649,806,000.00
- ACHV N/A
- Revenue This Year
- CATO N/A
- ACHV N/A
- Revenue Next Year
- CATO N/A
- ACHV N/A
- P/E Ratio
- CATO N/A
- ACHV N/A
- Revenue Growth
- CATO N/A
- ACHV N/A
- 52 Week Low
- CATO $2.19
- ACHV $1.84
- 52 Week High
- CATO $6.70
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- CATO 51.00
- ACHV 46.09
- Support Level
- CATO $2.20
- ACHV $2.32
- Resistance Level
- CATO $2.56
- ACHV $2.69
- Average True Range (ATR)
- CATO 0.18
- ACHV 0.18
- MACD
- CATO 0.05
- ACHV 0.02
- Stochastic Oscillator
- CATO 92.68
- ACHV 17.07
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.